Search…

Pipeline & Risk

Helix Instruments · the deal worktable — what’s real, what’s at risk, and what to do about it.

DIAGNOSE
Pilot
LIVEData as of 29 May 2026, 16:42 · last feed run 11 min ago
Back to Cockpit
Open opps
201
4 types
The live book the to-go number leans on.
Weighted pipeline
$117.8M
win-rate × land-prob
Risk-adjusted for both winning and landing in period.
Win-rate re-weight
−$17.9M
agent vs rep call
The agent haircuts the rep call — optimism in the book.
At-risk deals
85
low land-prob or over-called
Each is a slippage candidate — draft an ask before it moves.
Deal value × risktop-right = high value, high risk → de-risk first
Meridian Biosciences — MX-9 fleet expansion: $6.4M · risk 60%Equinox Diagnostics C — renewal: $4.2M · risk 60%Equinox Diagnostics D — channel: $4.2M · risk 34%Pinnacle Research C — new: $4.2M · risk 77%Pinnacle Research — expansion: $4.2M · risk 98%Cyto Analytics C — new: $4.2M · risk 91%Cobalt Materials B — renewal: $4.1M · risk 97%Cascade Metrology C — new: $4.1M · risk 96%Meridian Metrology B — renewal: $4.1M · risk 61%Tessera Instruments — channel: $4.1M · risk 35%Orbital Instruments D — renewal: $4.0M · risk 52%Vector Labs B — renewal: $4.0M · risk 88%Northwind Materials — channel: $4.0M · risk 56%Aperture Technologies C — new: $4.0M · risk 61%Tessera Instruments B — channel: $4.0M · risk 42%Cyto Analytics D — new: $3.9M · risk 89%Axion Biosciences — channel: $3.9M · risk 49%Quantix Sensing B — renewal: $3.9M · risk 55%Halcyon Technologies D — renewal: $3.8M · risk 39%Helios Biosciences — channel: $3.8M · risk 48%Sentient Systems D — channel: $3.8M · risk 41%Quantix Sensing B — renewal: $3.8M · risk 82%Axion Biosciences D — expansion: $3.8M · risk 96%Sentient Systems — channel: $3.7M · risk 80%Cobalt Materials — renewal: $3.7M · risk 91%Helios Biosciences E — expansion: $3.6M · risk 78%Strata Therapeutics A — channel: $3.6M · risk 96%Borealis Sensing C — expansion: $3.6M · risk 88%Quantix Sensing E — new: $3.6M · risk 82%Probe Therapeutics B — new: $3.5M · risk 78%Cobalt Materials E — new: $3.5M · risk 66%Nimbus Systems — expansion: $3.5M · risk 90%Northwind Materials A — renewal: $3.5M · risk 47%Vanta Labs F — renewal: $3.5M · risk 92%Helios Biosciences C — channel: $3.4M · risk 87%Calibrium Research D — new: $3.4M · risk 89%Pinnacle Research D — renewal: $3.4M · risk 70%Nimbus Systems C — channel: $3.4M · risk 32%Quantix Sensing C — channel: $3.3M · risk 46%Quantix Sensing A — channel: $3.3M · risk 50%← saferriskier →$6.4Mdeal value

Opportunities — agent-re-weighted

top 16 by value · Δ = agent vs rep · land % = time-to-recognize
OpportunityStageCallAmountRep %Agent %Land %Flags
Meridian Biosciences — MX-9 fleet expansion
Ava Castellano · expansion
negotiatecommit$6.4M85%72%▾1355%
ungroundedwon’t land
Equinox Diagnostics C — renewal
Sven Bergström · renewal
negotiatecommit$4.2M70%57%▾1269%
ungrounded
Equinox Diagnostics D — channel
Theo Lindqvist · expansion
negotiatecommit$4.2M87%83%▾480%
Pinnacle Research C — new
Ingrid Diaz · channel
developpipeline$4.2M29%26%▾390%
Pinnacle Research — expansion
Ava Castellano · expansion
negotiatecommit$4.2M80%72%▾82%
won’t landstale
Cyto Analytics C — new
Diego Ferreira · new
qualifypipeline$4.2M13%12%74%
stale
Cobalt Materials B — renewal
Marco Petrov · channel
proposepipeline$4.1M60%49%▾106%
won’t land
Cascade Metrology C — new
Priya Haddad · expansion
negotiatecommit$4.1M68%61%▾86%
won’t landstale
Meridian Metrology B — renewal
Clara Mehta · channel
proposepipeline$4.1M53%44%▾990%
Tessera Instruments — channel
Theo Lindqvist · channel
negotiatecommit$4.1M74%74%87%
Orbital Instruments D — renewal
Ravi Brandt · expansion
proposebest-case$4.0M62%53%▾992%
stale
Vector Labs B — renewal
Lena Olsen · channel
qualifybest-case$4.0M17%16%72%
Northwind Materials — channel
Noah Reyes · new
proposebest-case$4.0M51%50%88%
stale
Aperture Technologies C — new
Noah Reyes · renewal
negotiatecommit$4.0M67%59%▾865%
Tessera Instruments B — channel
Liam Andersen · expansion
negotiatecommit$4.0M70%62%▾893%
Cyto Analytics D — new
Omar Bauer · new
qualifyomitted$3.9M14%12%▾296%